Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1) : Implications for an integrated model of MEN-1 tumorigenesis

Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant tumor syndrome associated with parathyroid, gastroenteropancreatic (GEP), and pituitary neoplasia. Gastrinoma and GEP malignancy are common life-threatening endocrine complications of MEN-1. An effective management strategy for the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 1999-11, Vol.86 (10), p.2154-2159
Hauptverfasser:	BURGESS, J. R, GREENAWAY, T. M, PARAMESWARAN, V, SHEPHERD, J. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic agents Antineoplastic Agents, Hormonal - therapeutic use Biological and medical sciences Chemotherapy Female Gastrins - blood Gastrointestinal Neoplasms - drug therapy Humans Medical sciences Middle Aged Models, Biological Multiple Endocrine Neoplasia Type 1 - drug therapy Octreotide - therapeutic use Pancreatic Neoplasms - drug therapy Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!